Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/MammaPrint> ?p ?o }
Showing triples 1 to 53 of
53
with 100 triples per page.
- MammaPrint abstract "MammaPrint is a diagnostic test to assess the risk that a breast tumor will metastasize to other parts of the body. This helps physicians determine whether or not each patient will benefit from chemotherapy. MammaPrint is part of the Symphony Suite of breast cancer decision support tests marketed by Agendia.MammaPrint is based on the Amsterdam 70-gene breast cancer gene signature. It uses paraffin embedded or fresh tissue for the microarray analysis.In February 2007, the U.S. Food and Drug Administration (FDA) cleared the MammaPrint test for use in the U.S. for lymph node negative breast cancer patients of all ages, ER negative or ER positive, with tumors of less than 5 cm.The cost of the assay in the U.S. is $4,200. In Europe, the test costs EUR 2675.".
- MammaPrint wikiPageExternalLink www.agendia.com.
- MammaPrint wikiPageExternalLink 487.php.
- MammaPrint wikiPageExternalLink 479.php.
- MammaPrint wikiPageExternalLink 522.php.
- MammaPrint wikiPageID "3208464".
- MammaPrint wikiPageLength "12891".
- MammaPrint wikiPageOutDegree "27".
- MammaPrint wikiPageRevisionID "678958198".
- MammaPrint wikiPageWikiLink Adjuvant_therapy.
- MammaPrint wikiPageWikiLink Anthracycline.
- MammaPrint wikiPageWikiLink Biomarker_(medicine).
- MammaPrint wikiPageWikiLink Breast_cancer.
- MammaPrint wikiPageWikiLink Breast_cancer_classification.
- MammaPrint wikiPageWikiLink Capecitabine.
- MammaPrint wikiPageWikiLink Category:Microarrays.
- MammaPrint wikiPageWikiLink Chemotherapy.
- MammaPrint wikiPageWikiLink Clinical_trial.
- MammaPrint wikiPageWikiLink Diagnosis.
- MammaPrint wikiPageWikiLink Docetaxel.
- MammaPrint wikiPageWikiLink Estrogen_receptor.
- MammaPrint wikiPageWikiLink Food_and_Drug_Administration.
- MammaPrint wikiPageWikiLink Hormonal_therapy_(oncology).
- MammaPrint wikiPageWikiLink Letrozole.
- MammaPrint wikiPageWikiLink Metastasis.
- MammaPrint wikiPageWikiLink Microarray.
- MammaPrint wikiPageWikiLink National_Cancer_Institute.
- MammaPrint wikiPageWikiLink Neoadjuvant_therapy.
- MammaPrint wikiPageWikiLink Oncogenomics.
- MammaPrint wikiPageWikiLink Personal_genomics.
- MammaPrint wikiPageWikiLink Personalized_medicine.
- MammaPrint wikiPageWikiLink Symphony_(Agendia).
- MammaPrint wikiPageWikiLink Tamoxifen.
- MammaPrint wikiPageWikiLinkText "MammaPrint main article".
- MammaPrint wikiPageWikiLinkText "MammaPrint".
- MammaPrint wikiPageUsesTemplate Template:Refimprove.
- MammaPrint wikiPageUsesTemplate Template:Reflist.
- MammaPrint subject Category:Microarrays.
- MammaPrint hypernym Test.
- MammaPrint type Cricketer.
- MammaPrint type Genomic.
- MammaPrint type Method.
- MammaPrint type Technique.
- MammaPrint comment "MammaPrint is a diagnostic test to assess the risk that a breast tumor will metastasize to other parts of the body. This helps physicians determine whether or not each patient will benefit from chemotherapy. MammaPrint is part of the Symphony Suite of breast cancer decision support tests marketed by Agendia.MammaPrint is based on the Amsterdam 70-gene breast cancer gene signature. It uses paraffin embedded or fresh tissue for the microarray analysis.In February 2007, the U.S.".
- MammaPrint label "MammaPrint".
- MammaPrint sameAs Q2009487.
- MammaPrint sameAs ממפרינט.
- MammaPrint sameAs MammaPrint.
- MammaPrint sameAs m.08zdw7.
- MammaPrint sameAs Маммапринт.
- MammaPrint sameAs Q2009487.
- MammaPrint wasDerivedFrom MammaPrint?oldid=678958198.
- MammaPrint isPrimaryTopicOf MammaPrint.